Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

European healthcare stocks hit fresh lows after Trump's tariff threat

Published by Global Banking and Finance Review

Posted on August 6, 2025

Featured image for article about Finance

MILAN (Reuters) -Healthcare stocks led sectoral decliners in Europe on Wednesday, as President Donald Trump's latest threat of higher tariffs on pharmaceutical imports kept traders on edge.

Trump said on Tuesday that Washington would initially impose a "small tariff" before raising it to 150% within 18 months, and eventually to 250%, in a bid to boost domestic production.

The STOXX Healthcare index fell as much as 1.7% by 0933 GMT, hitting its lowest level in over three months and bringing year-to-date losses close to 10%. Among the top fallers were Swiss drugmakers Novartis and Roche.

Shares in weight-loss drugmaker Novo Nordisk struggled to stabilise after last week's rout following a profit warning. The stock was last down over 1.9%.

(Reporting by Danilo Masoni; Editing by Amanda Cooper)